StageMark

About:

StageMark develops and markets inflammatory diseases identification and monitoring solutions.

Top Investors: BioAdvance, Innovation Works, Science Center, Meyer Ventures, BlueTree Allied Angels

Description:

StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.

Total Funding Amount:

$2.45M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2004-01-01

Founders:

Bernard Cambou, Joseph Ahearn, Susan Manzi

Number of Employees:

11-50

Last Funding Date:

2007-04-23

IPO Status:

Private

Industries: